Iron (III)-hydroxide polymaltose complex

Therapeutic Segment

Generic Name

Indication

It is indicated for: The treatment of latent iron deficiency; manifest iron deficiency; prophylactic therapy of iron deficiency before, during and after pregnancy (during lactation).

Brands

Form